The Standard

The Official Blog of Health Level Seven® International


CodeX-Uncovering the Potential of REMS Automation: A Journey Towards Interoperability

[fa icon="calendar"] Apr 17, 2024 5:03:55 PM / by Kelee Petzelt

codex logo 2024

This quarter has brought with it a lot of excitement for us to dive into the great realm of REMS (Risk Evaluation and Mitigation Strategies) automation and its profound impact on our healthcare landscape. Buckle up, because we're about to review a thrilling journey we've been moving down towards greater efficiency, collaboration, and, most importantly, patient care!

Picture this: a world where cumbersome REMS processes are a thing of the past, replaced by seamless automation that not only streamlines workflows but also enhances patient outcomes. I know it sounds farfetched; however, I feel this dream is swiftly becoming a reality!

At the heart of this revolution lies a collective effort to transition from mere discussions to concrete actions. Through initiatives like HL7 CodeX and NCPDP (National Council for Prescription Drug Programs), we're witnessing a relentless commitment to leveraging standardized practices for interoperability and data exchange. I recently had the privilege of participating in the HL7 Connectathon, where the REMS Integration use case showcased the power of community collaboration. And guess what? We're gearing up to ballot the patient enrollment IG in May – talk about momentum!

But our quest doesn't stop there. We're just getting started! Events like the REMS Innovation Consortium (RIC) have served as epicenters of brainstorming, where industry pioneers gather to explore new horizons in patient care. Together, we're shattering the confines of traditional REMS programs and paving the way for groundbreaking innovations.

And let's not forget our champions – the FDA and standards organizations – who stand as beacons of support in our journey toward continuous evaluation and refinement. With their backing, we're empowered to navigate the ever-evolving landscape of healthcare regulations while staying true to our mission of enhancing patient safety.

But perhaps the most exhilarating aspect of REMS automation is its potential to unite stakeholders from all corners of the healthcare ecosystem. From healthcare providers to pharmaceutical giants and tech wizards, collaboration is the name of the game. Together, we're dismantling barriers, embracing new technologies like AI and machine learning, and forging a future where information flows seamlessly for the betterment of patient care. Automated REMS for pharmaceutical companies is driving the shift towards value-based care (VBC) by delivering cleaner, more actionable data. Through streamlined processes and advanced analytics enabled by AI and machine learning, pharmaceutical firms can effectively demonstrate the value of their therapies, paving the way for more informed decision-making and improved patient outcomes in the evolving healthcare landscape. So, my fellow trailblazers, I urge you to join us in this quest. Whether you're a provider, a pharmacist, or a tech enthusiast, there's a role for you to play in shaping the future of healthcare delivery. Together, let's uncover the full potential of REMS automation and usher in a new era of interconnected, patient-centric care.

Between the excitement generated at the RIC, NCPDP's standards, and CodeX’s momentum and progress, there's no limit to what we can achieve. Together, let's seize this opportunity and pave the way for a future where REMS automation knows no bounds!

Excited? I am! Let's make REMS automation not just a dream, but a foundational reality. Together, we can do this! To join our efforts, please reach out to Kelee Petzelt, CodeX’s REMS Integration Use Case Manager for ways you can get involved!

Topics: FHIR, interoperability, FHIR Accelerator, CodeX, Risk Evaluation and Mitigation Strategies, NCPDP

Kelee Petzelt

Written by Kelee Petzelt

Kelee Petzelt is a Consultant for Point-of-Care Partners (POCP) where she utilizes her skills in identifying opportunities in improving organizational performance in the areas of pharmacy systems, life sciences, and pharmacogenetic/genomics. She also serves as the REMS (Risk Evaluation and Mitigation Strategies) Use Case Coordinator for CodeX, leveraging HL7 FHIR to exchange data to support the safe use of FDA approved medications. She is a subject matter expert in pharmacogenomics and an author of blogs and publications focused on implementing pharmacy guided PGx solutions into the workflow.

Lists by Topic

see all

Posts by Topic

see all